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ABSTRACT 
Objective: Evaluation Of Famotidine Loaded 3D-Nano-Cellulose Network three dimensional nano-cellulose network (3DNC) Used For Oral 
Administration. 3DNC is produced from bacteria living in fermented green tea and is the material containing nano-sized fibers, which is capable of 
loading Famotidine to form a prolonged release therapy to improve drug bioavailability.  
Methods: Used healthy white rabbits, weight approximately 2.5-2.7 kg, the same age, laboratory standard, is supplied from The National Institute of 
Drug Quality Control. The rabbits have adapted to laboratory conditions at least one week and have starveling in 12 h, supplied fully water during 
the preparation. Rabbits are divided into 4 groups (n=3 for each group). Every rabbit is given 1 capsule or 1 tablet with a single dose of 20 
mg/rabbit: group 1 (commercial drugs), group 2 (3DNC-standard medium (SM) loaded drug), group 3 (3DNC-coconut medium (CM) loaded drug) 
Group 4 (3DNC-rice medium (RM) loaded drug). 
Results: The results have shown that 3DNC has the involvement of the nano-sized cellulose fibers with three-dimensional networks that are capable of 
loading Famotidine and prolonged drug release. The 3DNC cultured in the drug-loaded SM with slow-release and slow-release catalysts, the 3DNC was 
cultured in CMs and tablets with medium release rates, in comparison with the 3DNC was cultured in RM loaded at a rapid release rate in the same pH = 2. 
Conclusion: Experiment on rabbits showed that the drug-loaded 3DNCs could help to prolong the drug release, in which the extended-release time 
of the 3DNC cultured in SM and CM was higher than that of the 3DNC grown in RM. The 3DNC loaded drugs help improve Famotidine bioavailability 
compared to commercial tablets.  
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INTRODUCTION 
The 3DNC has the structure of super-thin nanofibers, great tensile, 
mechanical strength, and so on. Some studies have proved that the 
3DNC has the potential of being a delivery system with its 
properties. Amin M. C. I. M et al. [1] have indicated that the 3DNC 
membranes can increase the releasing time of the drug and improve 
the efficiency of drug use. Huang L. et al. [2] have controlled the 
drug-releasing of the 3DNC in artificial models, including the 
stomach and intestine. The gained information has shown that 
Berberine released with a low rate in acidic condition, normal in 
alkaline condition and high releasing rate in neutral pH condition. 
Satishbabu B. K. et al. [3] have assessed slowly releasing drug rate of 
Famotidine on the cod liver oil combined with calcium alginate 
granules. Anraku M. et al. [4] have studied the slow release of 
Famotidine from tablets: chitosan/sulfobutyl ether β-cyclodextrin 
composites. Zhu X. et al. [5] have studied the drug delivery system 
that increased the bioavailability of Famotidine in rats. Maday F. M. 
et al. [6] have evaluated the acid function of carboxymethyl-beta-
cyclodextrin in improving the chemical stability, oral-route 
bioavailability, and bitter taste of Famotidine. Fahmy R. H. et al. [7] 
have tested the rate of release of Famotidine through the 
construction of liquisolid tablets in both in vitro and in vivo. Gao S. et 
al. [8] have studied the pharmacokinetics and bioavailability of 
Famotidine on 10 Chinese volunteers. The ọbjective of study is the 
evaluation Of Famotidine Loaded 3D-Nano-Cellulose Network three 
dimensional nano-cellulose network (3DNC) used for oral 
administration.  
MATERIALS AND METHODS 
Materials and chemicals: Famotidine 99.5% (Sigma–The USA); 
tablets Famotidine (FAMSYN-20, Haryana–India); Dialysis bag 
(MWCO: 12000-14000; Serva–Germany); Yeast extract (USA); 
Peptone (European Union); Methanol, Acetonitrile, Sodium Acetate 
Trihydrate, Triethylamine, Ice Acetic Acid,… (Merck); other standard 
chemicals used in chromatography and analysis. 
Laboratory Animal: healthy white rabbits, weight approximately 2.5-
2.7 kg, the same age, laboratory standard, is supplied from The 
National Institute of Drug Quality Control. The rabbits have adapted 
to laboratory conditions at least one week and have starveling in 12 
h, supplied fully water during the preparation. Experiments on 
rabbits have been approved by the ethical committee for conduction 
the study, approval number: 458/Ministry of Health of Vietnam.  
Determine the physicochemical properties of 3DNC loaded 
famotidine 
The material structure 3DNC loaded drug by scanning electron 
microscope (SEM), in which the sample heat in 40 °C is in 20 min. 
The next step is to cover a thin platinum layer and then put it into 
the sample chamber.  
Use the electron microscope FE-SEM Hitachi S-4800 with 
magnification M=20-800,000×, resolution δ = 1.0 NM and 
piezoelectric accelerator U = 10kV. 
Determine the interaction of 3DNC with the drug by the photo 
spectrometer Fourier transformation infrared (FT-IR): Samples are 
directly measured by reflectometry in 20 °C, moisture 40-43%. 
Research the drug release from 3DNC loaded drug in vitro 
Drug dose, which was released through the delivery system was tested 
in buffer solution pH=2; 4.5; 6.8 [9]. According to the Pharmacopoeia 
of Vietnam [10]. Put 3DNC loaded drug in the dialysis bag, which is 
dipped in a buffer solution with specific pH (2; 4.5; 6.8) [10] during the 
night with a closed side, then add 5 ml buffer solution with pH levels 
respectively. Use Magnetic Stirrer, stirring speed 50 cycles/min, the 
temperature in range 37 °C±0.5 °C. After 0.5h; 1h; 1.5; 2h; 4h; 6h; 8h; 
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12h and 24h, take samples out to measure the spectral density of the 
samples. The samples were removed at every 5 ml intervals and 
adding again 5 ml of a buffer solution. The experiments were repeated 
three times for the mean value. The ratio of drug release is calculated 
according to the formula:  
 
Where: R is the drug release ratio; Ct is the concentration of the 
solution at time t; V1 is the volume of buffer solution at different pH 
values; n are the number of samples taken from the solution of 
liberation; V2 is the volume of buffer added; m is the amount of drug 
absorbed into the 3DNC. 
Research the bioavailability of 3DNC loaded drug in vivo  
Testing requirement: 12 laboratory rabbits divided into 4 groups 
(n=3 for each group). Every rabbit has given 1 capsule or 1 tablet 
with a single dose of 20 mg/rabbit: group 1 (commercial drugs), 
group 2 (3DNC-SM loaded drug), group 3 (3DNC-CM loaded drug) 
Group 4 (3DNC-RM loaded drug). 
Sampling method: After the rabbits take the drugs, use blood samples 
taken from those rabbits before giving the drug (white drug without any 
medicine), then take blood in turn at 0.5h, 1h, 2h, 4h, 6h, 8h, 10h, 12h, 
and 24h after drug use [9]. Select suitable veins, the blood is collected 
behind the ear. Using a sterilized needle to aspirate the vein behind 
rabbit ears, blood in the test the tube contains anti-coagulants (EDTA). 
Only after taking the blood samples, was it gently inversed repeatedly to 
ensure well mixing with anticoagulants and immediately centrifuged at 
5000 rpm for 10 min at 4 °C to separate the plasma. Floating plasma will 
be transferred to a clean tube and start to analyze [9]. 
Quantify Fa in blood plasma by high-performance liquid 
chromatography (HPLC) method: Survey the chromatography 
condition, sampling process and evaluate the analytic technique 
based on our previous results. 
Assessing parameters bioavailability in vivo 
Maximum concentration (Cmax): Maximum concentration exposes the 
intensity of interaction of drugs. The more absorbed the drug is, the 
faster it reaches the maximum concentration. These concentrations 
must be higher than the minimum concentration to exhibit clinical 
responses. However, if the maximum concentration overtakes the 
safety threshold, the drug will be able to cause unwanted sides [11]. 
To evaluate bioavailability (BIOA), we use relative BIOA (formula 
2.4) when the control products is an oral medication. 
 
Where: AUCtest is the curve area of testing drug; AUCstandard is curve 
area of control drug; Dtest is the testing dose of the testing drug; 
Dstandard is the testing dose of control drug. 
If the testing products have BIOA = 80-125% compared to the 
control products, it will be considered that is biological equivalence 
with the control products [11]. All results are analyzed, processed by 
Excel 2010, and the pharmacokinetic parameters were calculated, 
processed by PK Solver software [12]. 
RESULTS AND DISCUSSION 
Evaluate the release capacity of famotidine from 3DNC loaded 
drug in vitro 
Conduct drug release in vitro from the 3DNC loaded materials under 
environmental conditions pH = 2; 4.5 and 6.8. The results of the drug 
release rate for the 3DNC types cultured in SM, CM, and RM loaded in 
the different pH media are shown in fig. 1. The results indicated that 
the 3DNC cultured in SM loaded drug after 12 h had a higher drug 
release rate at pH = 2 (88.79%) and pH = 4.5 (86.47%), lower than at 
pH = 6.8 (74.36%). At pH = 2 and pH = 4.5; the drug release rates 
from the 3DNC were cultured in SM slower but has a higher rate at 
pH = 6.8. After 12h, the drug release rate from the 3DNC in CM 
loaded drug has a high release rate of the Faat pH = 2 (88.11%) and 
at pH= 4.5 (89.99%), lower than pH = 6.8 (78.94%). The 3DNC 
cultured in CM loaded drug has been released at a faster rate at pH = 
6.8 and releases less than the remaining pH. Just after 6 h, the 3DNC 
was cultured in RM loaded with the high acid release rate at pH = 2 
(92.52%) and pH = 4.5 (93.19%), lower than at pH = 6.8 (83.69%). 
In the investigated pH, the 3DNC was cultured in RM loaded Fa 
having a fast and high rate of drug release. 
 
 
a) 3DNC produced from SM loaded drug (n = 3), n: number of experiments; mean±SD: pH = 2 (62.1±0.29); pH = 4.5 (61.3±0.18); pH = 6.8 
(55.2±0.34) 
 
The results in fig. 1 stated that just after 6 h, commercial tablets 
Famotidine had a high rate of Fa release at pH = 2 (84.45%), lower 
than pH = 4.5 (78.16%) and pH = 6.8 (69.00%). At pH = 2, the rate of 
drug release from commercial tablets Fa was slower but higher than 
at pH = 4.5 and at pH = 6.8. 
The comparison results of the pH effect on the drug release capacity of 
each drug-loaded 3DNC and of the commercial tablets Fa are shown in 
fig. 1. The results expressed that in highly acidic environments (pH = 
2), each drug-loaded 3DNC, as well as the commercial tablets, had a 
higher Fa release rate than pH = 4.5 and pH = 6.8. This evidence may 
explain that Fa is well soluble in the acidic environment, so the drug 
will release better from the drug-loaded 3DNC as well as from the 
tablets. The result is consistent with other studies [2, 13]. 
The comparative results on the Fa release capacity of three drug-
loaded 3DNC types and commercial tablets Fa in the media pH = 2; 
pH = 4.5 and pH = 6.8 was shown in fig. 2. 
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d) Commercial Famotidine tablets (n = 3), n: number of experiments; mean±SD: pH = 2 (56.4±0.14); pH = 4.5 (57.7±0.17); pH = 6.8 
(62.6±0.39) 
Fig. 1: Percentage of Famotidine release from the 3DNC produced from SM, CM, and RM loaded drug in the different pH environments 
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a) pH = 2 (n = 4), n: number of experiments; mean±SD: SM (66.7±0.33); CM (68.0±0.26); RM (74.6±0.30); TABLET (67.5±0.23) 
 
 
b) pH = 4.5; (n=4), n: number of experiments; mean±SD: SM (70.9±0.25); CM (75.6±0.22); RM (83.1±0.18); TABLET (61.6±0.28) 
 
 
c) pH = 6.8; (n=4), n: number of experiments; mean±SD: SM (55.3±0.34); CM (58.6±0.33); RM (64.3±0.32); TABLET (57.7±0.24) 
Fig. 2: Percentage of Famotidine released from three 3DNC types loaded drug and commercial tablets Famotidine in distinct pH 
environments 
 
Research results showed that the 3DNC cultured in the drug-loaded 
SM with slow-release and slow-release catalysts, the 3DNC was 
cultured in CMs and tablets with medium release rates, whereas the 
3DNC was cultured in RM loaded at a rapid release rate in the same 
pH = 2 medium. This can be explained by the SEM image showing 
that the size of the hole in the membrane is larger and that the 
number of holes is greater than the other ones, thus releasing the 
drug to the environment faster. This result is consistent with other 
studies [2]. 
Hence, in high acidic environments (pH = 2), each drug-loaded 
3DNC, as well as the commercial tablets, had higher the pH release 
rates than at pH= 4.5 and pH = 6.8. The 3DNC cultured in drug-
loaded SM has a slow and prolonged release, the 3DNC cultured in 
the drug-loaded CM and tablets have medium release rates, whereas 
the 3DNC cultured in the drug-loaded RM has a fast release in the 
same pH environment. 
Evaluate bioavailability in vivo of famotidine release from 3DNC 
The analytic progress of Fa in the rabbit plasma was built, including 
sampling processes and analytical methods by HPLC. Throughout 
the survey, methanol solvent samples were selected, high-
performance liquid chromatography conditions suitable for 
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columns, mobile phases, detectors, flow rates, injection volumes 
allowed for Fa analysis in rabbit plasma with a small detective limit of 0.0644μg/ml and a quantity limit of 0.212 μg/ml [14]. The Fa 
quantitative procedure in rabbit plasma has been evaluated for 
specificity, linearity, defined range, definite limit, quantitative limit, 
correctness, accuracy, precision. The results of the study show that 
the method is suitable for estimating Fa in rabbit plasma [14]. The 
rabbit plasma samples obtained after oral administration of three 
doses of the drug-loaded 3DNC and Fa tablets with the same 
concentration of 20 mg/rabbit [15] were processed and quantified 
according to the method described in our previous study [14]. The 
results of the Fa determination of rabbit plasma concentration after 
drinking the three types of 3DNC loaded drugs and the Fa tablets are 
shown in table 1. 
 
Table 1: Famotidine concentration in rabbit plasma after administering three types of the drug-loaded 3DNC and Famotidine tablets with 
the same concentration 20 mg/rabbit (n = 3) 








0.5 2.641±0.154 5.641±0.154 6.917±0.292 6.479±0.979 
1 6.006±0.278 8.567±0.220 9.520±1.565 11.860±0.760 
2 9.751±0.286 9.504±0.279 11.318±0.656 14.015±0.933 
4 10.946±0.146 10.687±0.082 12.972±0.526 9.931±0.711 
6 11.723±0.138 11.410±0.190 11.518±0.332 7.887±1.068 
8 11.274±0.086 10.604±0.102 6.410±0.456 4.364±0.463 
10 8.906±0.465 8.037±0.182 3.974±0.245 2.666±0.319 
12 5.804±0.244 4.761±0.288 2.689±0.343 0.933±0.218 
24 0.834±0.047 0.517±0.277 0.207±0.103 0.031±0.006 
(n: number of experiments) 
 
The results in table 1, indicated that, at the early time of the survey, 
the rabbit plasma concentrations increased slowly in the rabbits 
using the 3DNC cultured from SM or the 3DNC cultured from CM but 
increased rapidly when the rabbits using the 3DNC cultured from 
drug-loaded RM or commercial tablets Fa. Almost all of the time, the 
Fa concentrations in the rabbit plasma using drug-loaded 
membranes are higher than the rabbits taking commercial tablets. 
To better illustrate the differences in plasma concentrations of Fa 
among four groups of rabbits, the data were expressed as a mean of 
the curve of Fa concentration following the time (fig. 3). 
 
 
Fig. 3: Expressing famotidine concentrations in rabbit plasma following the time (n=4), n: number of experiments; mean±SD: SM 
(7.9±0.48); CM (8.7±0.30); RM (9.3±0.35); TABLET (10.1±0.35) 
 
Table 2: Average pharmacokinetic parameters of three 3D-nano-cellulose structural network and commercial tablets famotidine (n= 4) 
Parameter Unit 3DNC cultured from SM 3DNC cultured from CM 3DNC cultured from RM Tablet 
Tmax hour 6 6 4 2 
Cmax μg/ml 11.72 11.41 12.97 14.02 
t1/2 hour 4.21 3.64 3.27 2.24 
AUC0-t hour. μg/ml 152.44 142.82 119.12 91.19 
AUC0-∞ hour. μg/ml 157.51 145.53 120.09 91.29 
(n: number of experiments) 
 
The indexes relating to the drug absorption by oral administration 
on rabbit groups taking the drug-loaded 3DNC types and commercial 
Fa tablets were shown in table 2. 
The results in table 2, showed that the rabbits using the 3DNC 
cultured from SM, 3DNC cultured from CM, the 3DNC cultured from 
the RM loaded drug and commercial tablets Fa obtained Cmax after 6, 
6, 4, 2 h, indicating that Fa in the commercial tablets is absorbed 
faster than the loaded Fa in the 3DNC types. Maximum drug 
concentrations in the plasma of the rabbits taking the drug-loaded 
3DNC were lower than the rabbits taking the commercial Fa tablets. 
The half-life (t1/2) and the area under the curve (AUC) of drug-loaded 
3DNCs were higher than the commercial Fa tablets. Tmax of the 3DNC 
cultured from SM and CM was higher than the 3DNC cultured from 
the drug-loaded RM and the commercial Fa tablets were the smallest 
Tmax. Thus, the types of 3DNC loaded drugs can help with the 
prolonged drug release, in which the extended-release time of 3DNC 
membrane cultured from SM and the 3DNC was cultured from CM 
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loaded higher than the 3DNC cultured from the RM loaded drug. The 
in vivo bioavailability of drug-loaded 3DNC cultured in the standard 
media was 172%, the drug-loaded 3DNC in the coconut nutrient 
culture was 159%, the drug-loaded 3DNC in rice nutrient cultures 
were 131% compared to the tablets on the market. The drug-loaded 
3DNCs have supports to improve the Fa bioavailability compared to 
commercial tablets. These results are similar to the study results 
assessing the Fa bioavailability in some other products [15]. 
CONCLUSION  
In strong acidic environments (pH=2), the 3DNC was cultured in SM 
with slow Famotidine release rate and extended-release (88.79% 
release rate) is the most effective one. Experiment on rabbits 
showed that the drug-loaded 3DNCs could help to prolong the drug 
release, in which the extended-release time of the 3DNC cultured in 
SM and CM was higher than that of the 3DNC grown in RM. The 
3DNC loaded drugs help improve Famotidine bioavailability 
compared to the commercial tablets. 
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